Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Johnson

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Drug and Alcohol Dependence|July 8, 2017
Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant usersEvan S Herrmann, Patrick S Johnson, Natalie R Bruner, et al.
Journal of Addiction Medicine|July 29, 2016
Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug UseMichael J Paul, Margaret S Chisolm, Matthew W Johnson, et al.
Plos One|April 24, 2019
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTRoland R Griffiths, Ethan S Hurwitz, Alan K Davis, et al.
Journal of Psychopharmacology (Oxford, England)|April 9, 2020
Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasksCecilia L Bergeria, Sean B Dolan, Matthew W Johnson, et al.
Behavioural Processes|November 21, 2021
At-risk drinking, operant demand, and cross-commodity discounting as predictors of drunk driving in underage college womenGideon P Naudé, Matthew W Johnson, Justin C Strickland, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2016
Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humansMatthew W Johnson, Katherine A MacLean, Michael J Caspers, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2021
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approachesAlbert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, et al.
Behavioural Processes|October 9, 2025
Time estimation variability in delay discounting: Model comparison and considerationsBrett W Gelino, Madison E Graham, Justin C Strickland, et al.
Experimental and Clinical Psychopharmacology|September 28, 2020
Methamphetamine administration dose effects on sexual desire, sexual decision making, and delay discountingMeredith S Berry, Natalie R Bruner, Evan S Herrmann, et al.
Drug and Alcohol Dependence|December 7, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorumMatthew W Johnson, Katherine A MacLean, Chad J Reissig, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Drug and Alcohol Dependence|July 8, 2017
Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant usersEvan S Herrmann, Patrick S Johnson, Natalie R Bruner, et al.
Journal of Addiction Medicine|July 29, 2016
Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug UseMichael J Paul, Margaret S Chisolm, Matthew W Johnson, et al.
Plos One|April 24, 2019
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTRoland R Griffiths, Ethan S Hurwitz, Alan K Davis, et al.
Journal of Psychopharmacology (Oxford, England)|April 9, 2020
Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasksCecilia L Bergeria, Sean B Dolan, Matthew W Johnson, et al.
Behavioural Processes|November 21, 2021
At-risk drinking, operant demand, and cross-commodity discounting as predictors of drunk driving in underage college womenGideon P Naudé, Matthew W Johnson, Justin C Strickland, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2016
Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humansMatthew W Johnson, Katherine A MacLean, Michael J Caspers, et al.
Journal of Psychopharmacology (Oxford, England)|February 22, 2021
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approachesAlbert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, et al.
Behavioural Processes|October 9, 2025
Time estimation variability in delay discounting: Model comparison and considerationsBrett W Gelino, Madison E Graham, Justin C Strickland, et al.
Experimental and Clinical Psychopharmacology|September 28, 2020
Methamphetamine administration dose effects on sexual desire, sexual decision making, and delay discountingMeredith S Berry, Natalie R Bruner, Evan S Herrmann, et al.
Drug and Alcohol Dependence|December 7, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorumMatthew W Johnson, Katherine A MacLean, Chad J Reissig, et al.
Pageof 18